{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T05:56:27Z","timestamp":1781157387241,"version":"3.54.1"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T00:00:00Z","timestamp":1779494400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008050","name":"Fundaci\u00f3n Cellex","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ejca.2026.116819","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T15:10:56Z","timestamp":1779721856000},"page":"116819","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Quality and safety of research biopsies in oncology clinical trials"],"prefix":"10.1016","volume":"242","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1380-0990","authenticated-orcid":false,"given":"Paolo","family":"Nuciforo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3932-0170","authenticated-orcid":false,"given":"Fiorella","family":"Ruiz-Pace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Jimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Comas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Fasani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8904-4330","authenticated-orcid":false,"given":"Cristina","family":"Viaplana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesar","family":"Sevillano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Serres-Cr\u00e9ixams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Roson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Saura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4653-6324","authenticated-orcid":false,"given":"Elena","family":"Elez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Oaknin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene Bra\u00f1a","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7556-7608","authenticated-orcid":false,"given":"Eva","family":"Mu\u00f1oz-Couselo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa Macarulla","family":"Mercade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Carles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2495-8139","authenticated-orcid":false,"given":"Josep","family":"Tabernero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enriqueta","family":"Felip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Garralda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5997-318X","authenticated-orcid":false,"given":"Rodrigo","family":"Dienstmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2026.116819_bib1","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/nrclinonc.2011.114","article-title":"The ethical use of mandatory research biopsies","volume":"8","author":"Olsen","year":"2013","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ejca.2026.116819_bib2","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1200\/JCO.19.01479","article-title":"Ethical framework for including research biopsies in oncology clinical trials: American society of clinical oncology research statement","volume":"37","author":"Levit","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2026.116819_bib3","unstructured":"World Medical Association. World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Participants. Accessed April 27, 2025. https:\/\/www.wma.net\/policies-post\/wma-declaration-of-helsinki."},{"key":"10.1016\/j.ejca.2026.116819_bib4","doi-asserted-by":"crossref","first-page":"e722","DOI":"10.1200\/JOP.18.00092","article-title":"What can be done to improve research biopsy quality in oncology clinical trials?","volume":"14","author":"Ferry-Galow","year":"2018","journal-title":"JCO Oncol Pract"},{"key":"10.1016\/j.ejca.2026.116819_bib5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1200\/JCO.2012.43.1718","article-title":"Use of research biopsies in clinical trials: are risks and benefits adequately discussed?","volume":"31","author":"Overman","year":"2013","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.ejca.2026.116819_bib6","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1001\/jamaoncol.2018.4640","article-title":"Assessment of reported trial characteristics, rate of publication, and inclusion of mandatory biopsies of research biopsies in clinical trials in oncology","volume":"5","author":"Parseghian","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ejca.2026.116819_bib7","first-page":"4","article-title":"Feasibility and first reports of the MATCH-R repeated biopsy trial at Gustav Roussy","volume":"4","author":"Recondo","year":"2020","journal-title":"npj Precis Oncol"},{"issue":"17","key":"10.1016\/j.ejca.2026.116819_bib8","doi-asserted-by":"crossref","first-page":"6770","DOI":"10.1158\/0008-5472.CAN-09-1795","article-title":"2009 biospecimen research network symposium: advancing cancer research through biospecimen science","volume":"69","author":"Moore","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2026.116819_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.17.00081","article-title":"High-content biopsies facilitate molecular analyses and do not increase complication rates in patients with advanced solid tumors","volume":"1","author":"Frenk","year":"2017","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.ejca.2026.116819_bib10","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1093\/annonc\/mdr383","article-title":"Sequential research-related biopsies in phase I trials: acceptance, feasibility and safety","volume":"23","author":"Gomez-Roca","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2026.116819_bib11","article-title":"Feasibility, safety, and adequacy of research biopsies for cancer clinical trials at an academic medical center","volume":"14","author":"Lee","year":"2019","journal-title":"PlosOne"},{"key":"10.1016\/j.ejca.2026.116819_bib12","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ejca.2018.08.003","article-title":"Image-guided tumour biopsies in a prospective molecular triage study (MOSCATO-01): what are the real risks?","volume":"103","author":"Prud\u2019homme","year":"2018","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2026.116819_bib13","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.1200\/JCO.19.03010","article-title":"Molecular landscape and actionable alterations in a genomically guided cancer clinical trial: National cancer institute molecular analysis for therapy choice (NCI-Match)","volume":"38","author":"Flaherty","year":"2020","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2026.116819_bib14","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41698-021-00234-8","article-title":"An analysis of research biopsy core variability from over 5000 prospectively collected core samples","volume":"5","author":"Bhamidipati","year":"2021","journal-title":"NPJ Precis Oncol"},{"issue":"2","key":"10.1016\/j.ejca.2026.116819_bib15","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1001\/jamaoncol.2025.5376","article-title":"Enhancing clinical cancer research through sharing of data and biospecimens","volume":"12","author":"Wildiers","year":"2026","journal-title":"JAMA Oncol."},{"issue":"11","key":"10.1016\/j.ejca.2026.116819_bib16","article-title":"Industry involvement and transparency in the mostcited clinical trials, 2019-2022","volume":"6","author":"Siena","year":"2023","journal-title":"JAMANetwOpen"},{"issue":"3","key":"10.1016\/j.ejca.2026.116819_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(22)00070-5","article-title":"Code of practice needed for samples donated by trial participants\u2014Sponsor\u2019s reply","volume":"23","author":"Warner","year":"2022","journal-title":"Lancet Oncol"},{"issue":"10","key":"10.1016\/j.ejca.2026.116819_bib18","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1200\/JCO.2007.14.5482","article-title":"Dose- and schedule-dependent inhibition of the mammalian target of rapamycin pathway with everolimus: a phase I tumor pharmacodynamic study in patients with advanced solid tumors","volume":"26","author":"Tabernero","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2026.116819_bib19","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1634\/theoncologist.2011-0043","article-title":"Outcomes of research biopsies in phase I clinical trials: the MD Anderson Cancer Center Experience","volume":"16","author":"El-Osta","year":"2011","journal-title":"Oncologist"},{"issue":"7","key":"10.1016\/j.ejca.2026.116819_bib20","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1002\/cncr.27916","article-title":"Feasibility and safety of sequential research-related tumor core biopsies in clinical trials","volume":"119","author":"Lee","year":"2013","journal-title":"Cancer"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804926006003?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804926006003?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T04:56:42Z","timestamp":1781153802000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804926006003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":20,"alternative-id":["S0959804926006003"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2026.116819","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quality and safety of research biopsies in oncology clinical trials","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2026.116819","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"116819"}}